2024-05-13 17:38:54
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections
Health/ 2023-07-22
Menarini and SciClone Sign Exclusive Lic...

Vaborem®,a patented combination of meropenem and vaborbactam,is expected to address the rising prevalence of carbapenem-resistant Klebsi...

MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19
Corporate/ 2023-07-24
MGC Pharmaceuticals Successfully Develop...

LONDON,Sept. 21,2022--MGC Pharmaceuticals Ltd. (LSE: MXC),(ASX: MXC),(OTC: MGCLF),is a European based bio-pharma company,focused on developi...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release